Vlad Coric - 05 Jan 2026 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role: Chief Executive Officer, Director
Signature: /s/ George Clark, Attorney-in-Fact
Issuer symbol: BHVN
Transactions as of: 05 Jan 2026
Net transactions value: -$73,780
Form type: 4
Filing time: 07 Jan 2026, 21:32:31 UTC
Previous filing: 17 Nov 2025
Next filing: 05 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Coric Vlad	Chief Executive Officer, Director	C/O BIOHAVEN LTD., 215 CHURCH STREET, NEW HAVEN	/s/ George Clark, Attorney-in-Fact	07 Jan 2026	0001704317

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHVN	Common Shares	Options Exercise	$0	+14,250	+0.79%	$0.000000	1,811,398	05 Jan 2026	Direct
transaction	BHVN	Common Shares	Tax liability	$73,780	-7,430	-0.41%	$9.93	1,803,968	05 Jan 2026	Direct	F1
holding	BHVN	Common Shares						1,195,275	05 Jan 2026	By: The Vlad Coric Family Trust	F2
holding	BHVN	Common Shares						740,546	05 Jan 2026	By: The Vladimir Coric Marital Trust	F2
holding	BHVN	Common Shares						109,565	05 Jan 2026	By: 401(K) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BHVN	Restricted Share Unit Award	Options Exercise	$0	-14,250	-33%	$0.000000	28,500	05 Jan 2026	Common Shares	14,250		Direct	F3, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
F2	These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3	Each restricted share unit represents the contingent right to receive one common share of the Issuer.
F4	The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.
F5	Not applicable.